Please use this identifier to cite or link to this item:
10.1161/CIRCULATIONAHA.116.025427
| Title: | Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients : An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) |
| Authors: | APEX Investigators Stukena, I. |
| Keywords: | anticoagulants;cardiology;cardiovascular diseases;intracranial hemorrhages;stroke;thrombosis;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;SDG 3 - Good Health and Well-being |
| Issue Date: | 14-Feb-2017 |
| Citation: | APEX Investigators & Stukena , I 2017 , ' Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients : An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) ' , Circulation , vol. 135 , no. 7 , pp. 648-655 . https://doi.org/10.1161/CIRCULATIONAHA.116.025427 |
| Description: | Members of the APEX Investigators working group are listed in Web of Science database publication. |
| DOI: | 10.1161/CIRCULATIONAHA.116.025427 |
| ISSN: | 0009-7322 |
| Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| Extended_Duration_Betrixaban.pdf | 177.18 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.